Difference between revisions of "Team:UCL/Human Practices"

 
(236 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
{{UCL/TemplateBefore}}
 
{{UCL/TemplateBefore}}
 +
 
<html>
 
<html>
 
<body>
 
<body>
−
<main class="cd-main-content">
+
−
     <div id="main-content-container">
+
<style>
 +
.fixed-bg {
 +
    background-image: url("https://static.igem.org/mediawiki/2016/9/98/T--UCL--backgroundhp.png");
 +
     min-height: 500px;
 +
    background-attachment: fixed;
 +
    background-position: center;
 +
    background-repeat: no-repeat;
 +
    background-size: cover;
 +
}
 +
</style>
  
−
<h2 align="center"> <font size="30"> <b>  OUR STORY </b> </font> </h2>
+
<div class="fixed-bg">  
−
<br>
+
<div style="height: 400px;"> </div>
−
<h3> <center> We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy comes important questions. Some believe that we should not meddle with the human ageing process and others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.</center> </h3>
+
−
                      <br>
+
−
                      <br>
+
−
<h3> <center> In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. </center> </h3>
+
−
                      <br>
+
−
           
+
−
<br>
+
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Public_Engagement"> <b> Public Engagement/General Public: </b> </a> Biosynthage wanted to create a project that addresses a current societal need and understand how ageing affects us in later life. Our interactions with the general public involved conducting surveys and talking to people on the streets of London.  </p>
+
<head>
  
−
<br>
 
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Elderly"> <b> Our visit to Hamburg dementia home: </b> </a> We have been talking to elderly people who are affected by age related diseases to understand how ageing  affects the ageing population first hand. Have a look at some of the stories of the people at the care home! </p>
+
            <div class="team10cover">
 +
<h1> <center> <font size = "2000px" > <font color = "white" > OUR STORY </font> </font> </center> </h1>  
 +
<h3> <center> <font color = "white" >  </font> </center> </h3>
  
 +
</div>
 
<br>
 
<br>
−
 
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Experts"> <b> The experts: </b> </a> From the very beginning we have engaged scientific experts in order to ensure that our project is addressing a genuine need as defined by those who know best. </p>
 
−
 
 
<br>
 
<br>
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Industry"> <b> Industry: </b> </a> To understand the context of ageing industries and where Biosynthage fits and find out how our ideas can be translated from lab to industry, we reached out to opinions of experts from the ageing industry. We received enthusiastic feedback about our idea, strengthen by a feeling of slow progress in ageing industries.  </p>
 
  
−
<br>
 
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Law_and_Regulation"> <b> Law in London: </b> </a> If people were living healthier lives for longer, how would this impact law? Will the minimum pension age increase? Will there be a shift in the social demographics? Will this be a good thing to London and the world? We have been talking to members of parliament and London assembly members to explore the long term impacts of our novel technologies. </p>
+
</head>
  
−
<br>
 
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Religion"> <b> Religion, Synthetic Biology and Ageing: </b> </a> We have realised that much of the elderly population is the most religious out of all age ranges. So we wanted to investigate the impact of religious perspectives on the science policy pertinent to our project (i.e. biotechnology, synthetic biology, gene therapy). Find out about what we learnt through our talks with religious members of the public, religious leaders and our round table event with religious community leaders. </p>
 
  
−
<br>
+
<main class="cd-main-content">
 +
    <div id="main-content-container">
 +
<center> <img src = "https://static.igem.org/mediawiki/2016/6/63/T--UCL--swirl.png" width="190" height="90"  style="margin-Top:-150px" > </center>
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Education"> <b> Education/Outreach: </b> </a> Our survey showed that not only do people feel like they don’t know enough about synthetic biology, but they wish that they learnt synthetic biology at school. We really enjoyed reaching out to the younger generation through our workshops, summer schools and building our app! </p>
 
−
<br>
 
  
  
−
<p> <font size="4"> <a href="https://2016.igem.org/Team:UCL/Human_Practices/Art"> <b> Ageing and art: </b> </a>  We really enjoyed exploring exhibitions that celebrate old age. Find out how we have incorporated art into our human practices!  </font> </p>
 
−
<br>
 
  
−
<h3> In the press </h3>
 
  
−
<p> We were able make more people aware of our project by getting our project advertised through the UCL website (Biochemical engineering News section). We are also working on getting the project advertised on the UCL newsletter (myUCL). </p>
+
<h3> <center> We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy come important questions. Some believe that we should not meddle with the human ageing process whereas others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.</center> </h3>
 +
                      <br>
 +
                      <br>
 +
<h3> <center> In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. Below is a timeline of events and activities that the UCL iGEM team were doing this summer! We have details of each event in our human practices <a href="https://2016.igem.org/Team:UCL/HP/Silver"> silver </a> page! </center> </h3>
  
 +
<br>
 +
<br>
 +
<h3> <center> Click <a href="https://2016.igem.org/Team:UCL/HP/Silver/Conclusion"> here </a> to find the conclusion of our story so far.  </center> </h3>          <br>           
 +
<br>
 +
<br>
  
−
<p> Also follow our vlog where we upload fun videos of the team members and vlog throughout our iGEM journey </p>
+
<img src = "https://static.igem.org/mediawiki/2016/0/00/T--UCL--timelin1.png" >
  
−
<h3> Is ageing a disease </h3>
+
<img src = "https://static.igem.org/mediawiki/2016/e/e0/T--UCL--timeline2.png" >
  
 +
<img src = "https://static.igem.org/mediawiki/2016/4/46/T--UCL--app929.png" >
  
  
  
−
</div>
+
</div></div>
−
 
+
−
 
+
 
</main>
 
</main>
 
</body>
 
</body>
 
</html>
 
</html>
 
{{UCL/TemplateAfter}}
 
{{UCL/TemplateAfter}}

Latest revision as of 02:27, 20 October 2016

<!DOCTYPE html>

UCL iGEM 2016 | BioSynthAge

OUR STORY



We are all stakeholders in ageing hence why Biosynthage has been steeped in controversy since its very inception. However, with controversy come important questions. Some believe that we should not meddle with the human ageing process whereas others believe that we should think of ageing as a disease in order to start treating it. Biosynthage has really enjoyed exploring the depths of many debates which has caused us to constantly stop and reevaluate the next step forward within our project. We are constantly realising that with every new person we speak to, we uncover depths of new perspectives we never knew existed within in our story.



In the following sections, you can have a glimpse at the decisive factors that drove our project and continue to influence the progress of our novel technologies in the future. Below is a timeline of events and activities that the UCL iGEM team were doing this summer! We have details of each event in our human practices silver page!



Click here to find the conclusion of our story so far.